Objectives Open-labelled clinical trials suggested that low-dose IL-2 might be effective in treatment of systemic lupus erythematosus (SLE). A double-blind and placebo-controlled trial is required to ...

In a new study, researchers identify biomarkers that may predict the efficacy of low-dose IL-2 (Ld-IL2) treatment in people with systemic lupus erythematosus (SLE). IL-2 stands for interleukin-2 – a ...

Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic Antibody, AU-007, at 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting October 04, 2024 09:05 AM Eastern ...

Background: TransCon IL-2 β/γ is a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 analog (IL-2 β/γ) designed to optimally address the drawbacks of interleukin-2 (IL-2) ...

Iovance Biotherapeutics Inc (NASDAQ: IOVA) has agreed to acquire worldwide rights to Proleukin (aldesleukin), an interleukin-2 (IL-2) product, from Clinigen Limited. Iovance expects the benefits ...

Sound Devices is shipping the A20-RX: a two channel, true diversity receiver with industry-exclusive SpectraBand technology. SpectraBand gives the A20-RX receiver and A20-Mini transmitter an ...

Moderna’s IL-2 cull is not the first time the company has taken an ax to its non-COVID projects, having ditched a phase 2 cancer treatment in August 2021. Moderna autoimmune disease Earnings ...

A first-in-human, multicenter, phase 1/2, open-label study of XTX202, a masked and tumor-selective recombinant human interleukin-2 (IL-2) protein, in patients with advanced solid tumors. Authors : ...

Nektar Therapeutics and Bristol Myers Squibb have halted development of bempegaldesleukin, ending a multibillion dollar bet on interleukin-2 (IL-2) as an immuno-oncology drug.

Visually, IL-2 Sturmovik won't be the best-looking game you see all year, but while its occasionally chuggy frame-rate may not sound amazing, the game itself always feels pretty fantastic.